HemA, a form of hemophilia caused by insufficient expression or gene mutation of coagulation factor VIII (FVIII), results in impaired blood clotting ability and can lead to life-threatening bleeding episodes, including intracranial hemorrhage. This evidence concerns the gene F8 and hemophilia.